Brand-Name Costs (Without Insurance): Oral Semaglutide (Rybelsus): List Price: $900-$1,000 per month 30-day supply (30 tablets) Must take daily Annual cost: $10,800-$12,000 Injectable Semaglutide (Wegovy): List Price: $1,349 per month 4-5 weekly injections per pack Weekly dosing Annual cost: $16,188 Injectable Tirzepatide (Zepbound): List Price: $1,069 per month 4 weekly injections per pack Weekly dosing Annual cost: $12,828 With Insurance Coverage: Oral Semaglutide: More likely to be covered for diabetes Weight loss coverage varies Copay: $25-$300/month with insurance Prior authorization usually required Injectable Semaglutide (Wegovy): Covered by some insurance for weight loss Copay: $25-$300/month with insurance Extensive prior authorization requirements May require failed weight loss attempts first Injectable Tirzepatide (Zepbound): Newer to market, less insurance coverage for weight loss Copay: $25-$300/month with insurance Even more restrictive prior authorization Many plans dont cover yet for weight loss Compounded Injectable Options: Compounded Semaglutide: TrimRx price: $199/month with annual commitment Other providers: $199-$599/month No insurance coverage but HSA/FSA eligible Annual cost: $2,388-$7,188 Compounded Tirzepatide: TrimRx price: $349/month with annual commitment Other providers: $349-$699/month No insurance coverage but HSA/FSA eligible Annual cost: $4,188-$8,388 No Compounded Oral Options: Compounding pharmacies cannot create oral semaglutide because the SNAC absorption technology is proprietary and patented

Add Doug Miller's supplement and business expertise and David Dodrill's drive to the mix, and you have a team that's quite simply been unstoppable as of late
They also come with cost, access barriers, and potential side effects
The use of the glucagon-like peptide-1 receptor agonist (GLP-1RA), semaglutide, significantly enhanced liver health in patients with metabolic dysfunction-associated steatohepatitis (MASH) in several ways, including reducing inflammation, metabolic dysfunction, and fibrosis progression, through both weight-dependent and distinct proteomic mechanisms, according to a study published in Nature Medicine
Nystrm T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B, Sjholm A